Target intelligence / Profile preview

Tescalcin (TESC)

Target
TESC
Molecular classification
EF-hand domain–containing protein, Calcium-binding protein, Scaffolding/Adaptor protein
01

Overview

Tescalcin (TESC) is a small, 24-kDa calcium-binding protein belonging to the EF-hand domain–containing family, closely related to calcineurin homologous proteins. It contains a single functional EF-hand motif, enabling Ca²⁺-sensing activity central to its function. TESC plays multiple critical cellular roles, including regulation of the plasma membrane Na⁺/H⁺ exchanger 1 (NHE1), which is vital for controlling intracellular pH and ion homeostasis. Beyond ion transport, tescalcin interacts with and modulates key signaling proteins such as glycogen synthase kinase 3 (GSK3), the COP9 signalosome subunit CSN4, and the c-Src/IGF1Rβ/STAT3 axis, thereby influencing processes like cell proliferation, differentiation, epithelial–mesenchymal transition, and cancer stem cell properties. TESC is overexpressed in several cancer types (notably colorectal, lung, gastric, and liver cancers) and acts as both a diagnostic biomarker and a potential therapeutic target. Its regulation of major signaling cascades links it to tumorigenesis and radioresistance, especially through the maintenance of cancer stem cell–like phenotypes in solid tumors.

Other names
Calcineurin B homologous protein 3CHP3TSCFLJ20607Calcineurin-like EF hand protein 3
02

Mechanism of action

Modulation of intracellular signaling pathways such as Akt–NF-κB, STAT3, MAPK/ERK. Regulation of Na⁺/H⁺ exchanger degradation and surface stability. Calcium-dependent protein–protein interactions. Regulation of kinase (e.g., GSK3) phosphorylation and activity. Interaction with COP9 signalosome components.

03

Biological functions

Regulation of Na⁺/H⁺ exchanger (NHE1) activityPositive regulation of myeloid cell differentiationPositive regulation of biosynthetic processesRegulation of cellular pHCell proliferationCell differentiationSignal transductionModulation of kinase signaling (e.g., GSK3, c-Src, STAT3)Regulation of COP9 signalosome activity
04

Disease associations

Cancer (colorectal cancer, non-small cell lung cancer, gastric cancer, hepatocellular carcinoma, glioma)Developmental abnormalities
05

Safety considerations

None specifically reported in literature to date; general concerns relate to potential impact on cell proliferation and differentiation if modulated systemically
06

Biomarkers

Overexpression in serum and tissue is a biomarker for colorectal cancerUpregulation in cancer stem cell–like populations in non-small cell lung cancer

Beyond the preview

Go deeper on Tescalcin (TESC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tescalcin (TESC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call